Inhibition of TGF-β Signaling Enables Human Corneal Endothelial Cell Expansion In Vitro for Use in Regenerative Medicine

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Okumura, Naoki ^a,b   Kay, EunDuck P ^a   Nakahara, Makiko ^a   Hamuro, Junji ^b   Kinoshita, Shigeru ^b   Koizumi, Noriko ^a  

^a DOSHISHA UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); COLLAGEN TYPE 1; FIBRONECTIN; PROTEIN ZO1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CELL EXPANSION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORNEA ENDOTHELIUM; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR BLOCKING; REGENERATIVE MEDICINE;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; CELL MEMBRANE; CELLS, CULTURED; COLLAGEN TYPE I; CORNEA; ENDOTHELIAL CELLS; ENDOTHELIUM, CORNEAL; FIBROBLASTS; HUMANS; PHENOTYPE; PRIMATES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84874363905     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058000     Document Type: Article

References (45)

1. Melles GR, Lander F, van Dooren BT, Pels E, Beekhuis WH (2000) Preliminary clinical results of posterior lamellar keratoplasty through a sclerocorneal pocket incision. Ophthalmology 107: 1850-1856; discussion 1857.
2. Price FW Jr, Price MO, (2005) Descemet's stripping with endothelial keratoplasty in 50 eyes: a refractive neutral corneal transplant. J Refract Surg 21: 339-345.
3. Gorovoy MS, (2006) Descemet-stripping automated endothelial keratoplasty. Cornea 25: 886-889.
4. Ishino Y, Sano Y, Nakamura T, Connon CJ, Rigby H, et al. (2004) Amniotic membrane as a carrier for cultivated human corneal endothelial cell transplantation. Invest Ophthalmol Vis Sci 45: 800-806.
5. Mimura T, Yamagami S, Yokoo S, Usui T, Tanaka K, et al. (2004) Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model. Invest Ophthalmol Vis Sci 45: 2992-2997.
6. Sumide T, Nishida K, Yamato M, Ide T, Hayashida Y, et al. (2006) Functional human corneal endothelial cell sheets harvested from temperature-responsive culture surfaces. FASEB J 20: 392-394.
7. Koizumi N, Sakamoto Y, Okumura N, Okahara N, Tsuchiya H, et al. (2007) Cultivated corneal endothelial cell sheet transplantation in a primate model. Invest Ophthalmol Vis Sci 48: 4519-4526.
8. Koizumi N, Sakamoto Y, Okumura N, Tsuchiya H, Torii R, et al. (2008) Cultivated corneal endothelial transplantation in a primate: possible future clinical application in corneal endothelial regenerative medicine. Cornea 27Suppl 1: S48-55.
9. Koizumi N, Okumura N, Kinoshita S, (2012) Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal models. Exp Eye Res 95: 60-67.
10. Okumura N, Ueno M, Koizumi N, Sakamoto Y, Hirata K, et al. (2009) Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci 50: 3680-3687.
11. Okumura N, Koizumi N, Ueno M, Sakamoto Y, Takahashi H, et al. (2012) ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. Am J Pathol 181: 268-277.
12. Miyata K, Drake J, Osakabe Y, Hosokawa Y, Hwang D, et al. (2001) Effect of donor age on morphologic variation of cultured human corneal endothelial cells. Cornea 20: 59-63.
13. Joyce NC, Zhu CC, (2004) Human corneal endothelial cell proliferation: potential for use in regenerative medicine. Cornea 23: S8-S19.
14. Zavadil J, Bottinger EP, (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24: 5764-5774.
15. Wendt MK, Allington TM, Schiemann WP, (2009) Mechanisms of the epithelial-mesenchymal transition by TGF-beta. Future Oncol 5: 1145-1168.
16. Saika S, (2006) TGFbeta pathobiology in the eye. Lab Invest 86: 106-115.
17. Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, et al. (2007) Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282: 22089-22101.
18. Chen KH, Harris DL, Joyce NC, (1999) TGF-beta2 in aqueous humor suppresses S-phase entry in cultured corneal endothelial cells. Invest Ophthalmol Vis Sci 40: 2513-2519.
19. Kim TY, Kim WI, Smith RE, Kay ED, (2001) Role of p27(Kip1) in cAMP- and TGF-beta2-mediated antiproliferation in rabbit corneal endothelial cells. Invest Ophthalmol Vis Sci 42: 3142-3149.
20. Naumann GO, Schlotzer-Schrehardt U, (2000) Keratopathy in pseudoexfoliation syndrome as a cause of corneal endothelial decompensation: a clinicopathologic study. Ophthalmology 107: 1111-1124.
21. Kawaguchi R, Saika S, Wakayama M, Ooshima A, Ohnishi Y, et al. (2001) Extracellular matrix components in a case of retrocorneal membrane associated with syphilitic interstitial keratitis. Cornea 20: 100-103.
22. Koizumi N, Suzuki T, Uno T, Chihara H, Shiraishi A, et al. (2008) Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology 115: 292-297 e293.
23. Song JS, Lee JG, Kay EP, (2010) Induction of FGF-2 synthesis by IL-1beta in aqueous humor through P13-kinase and p38 in rabbit corneal endothelium. Invest Ophthalmol Vis Sci 51: 822-829.
24. Li W, Sabater AL, Chen YT, Hayashida Y, Chen SY, et al. (2007) A novel method of isolation, preservation, and expansion of human corneal endothelial cells. Invest Ophthalmol Vis Sci 48: 614-620.
25. Zhu C, Joyce NC, (2004) Proliferative response of corneal endothelial cells from young and older donors. Invest Ophthalmol Vis Sci 45: 1743-1751.
26. Rheinwald JG, Green H, (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6: 331-343.
27. Koizumi N, Fullwood NJ, Bairaktaris G, Inatomi T, Kinoshita S, et al. (2000) Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest Ophthalmol Vis Sci 41: 2506-2513.
28. Ko MK, Kay EP, (2001) Subcellular localization of procollagen I and prolyl 4-hydroxylase in corneal endothelial cells. Exp Cell Res 264: 363-371.
29. Parsons CJ, Takashima M, Rippe RA, (2007) Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol 22Suppl 1: S79-84.
30. Ma FY, Sachchithananthan M, Flanc RS, Nikolic-Paterson DJ, (2009) Mitogen activated protein kinases in renal fibrosis. Front Biosci (Schol Ed) 1: 171-187.
31. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, et al. (2003) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968.
32. Simic P, Vukicevic S, (2007) Bone morphogenetic proteins: from developmental signals to tissue regeneration. Conference on bone morphogenetic proteins. EMBO Rep 8: 327-331.
33. Buijs JT, Rentsch CA, van der Horst G, van Overveld PG, Wetterwald A, et al. (2007) BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am J Pathol 171: 1047-1057.
34. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, et al. (2007) Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282: 23337-23347.
35. Barry PA, Petroll WM, Andrews PM, Cavanagh HD, Jester JV, (1995) The spatial organization of corneal endothelial cytoskeletal proteins and their relationship to the apical junctional complex. Invest Ophthalmol Vis Sci 36: 1115-1124.
36. Darlington JK, Adrean SD, Schwab IR, (2006) Trends of penetrating keratoplasty in the United States from 1980 to 2004. Ophthalmology 113: 2171-2175.
37. Price MO, Price FW Jr, (2010) Endothelial keratoplasty - a review. Clin Experiment Ophthalmol 38: 128-140.
38. Khaireddin R, Wachtlin J, Hopfenmuller W, Hoffmann F, (2003) HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection. Graefes Arch Clin Exp Ophthalmol 241: 1020-1028.
39. Coster DJ, Williams KA, (2005) The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol 140: 1112-1122.
40. Engelmann K, Bednarz J, Valtink M, (2004) Prospects for endothelial transplantation. Exp Eye Res 78: 573-578.
41. Mimura T, Shimomura N, Usui T, Noda Y, Kaji Y, et al. (2003) Magnetic attraction of iron-endocytosed corneal endothelial cells to Descemet's membrane. Exp Eye Res 76: 745-751.
42. Mimura T, Yamagami S, Yokoo S, Yanagi Y, Usui T, et al. (2005) Sphere therapy for corneal endothelium deficiency in a rabbit model. Invest Ophthalmol Vis Sci 46: 3128-3135.
43. Patel SV, Bachman LA, Hann CR, Bahler CK, Fautsch MP, (2009) Human corneal endothelial cell transplantation in a human ex vivo model. Invest Ophthalmol Vis Sci 50: 2123-2131.
44. Peh GS, Beuerman RW, Colman A, Tan DT, Mehta JS, (2011) Human corneal endothelial cell expansion for corneal endothelium transplantation: an overview. Transplantation 91: 811-819.
45. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, et al. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62: 65-74.